RNA-targeting therapies hold promise for contributing to HBV cure regimens, but challenges remain before that promise can be realized.
Targeting HBV with RNA interference: Paths to cure | Science Translational Medicine
RNA-targeting therapies hold promise for contributing to HBV cure regimens, but challenges remain before that promise can be realized.